Search Results - "Mohamedali, A"

Refine Results
  1. 1

    Evaluating interior surfaces including finishing materials, ceiling, and their contribution to solar energy in residential buildings in Famagusta, North-Cyprus, Turkey by Farjami, E., Mohamedali, A.

    Published in Renewable & sustainable energy reviews (01-08-2017)
    “…With the recent development of sustainable design trend, the major areas to consider are energy resources, construction techniques and materials, water usage…”
    Get full text
    Journal Article
  2. 2

    Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles by Zhang, Fan, Huang, Xinglu, Zhu, Lei, Guo, Ning, Niu, Gang, Swierczewska, Magdalena, Lee, Seulki, Xu, Hong, Wang, Andrew Y, Mohamedali, Khalid A, Rosenblum, Michael G, Lu, Guangming, Chen, Xiaoyuan

    Published in Biomaterials (01-07-2012)
    “…Abstract Noninvasive imaging techniques have been considered important strategies in the clinic to monitor tumor early response to therapy. In the present…”
    Get full text
    Journal Article
  3. 3

    Is isolation of comprehensive human plasma peptidomes an achievable quest? by Mahboob, S., Mohamedali, A., Ahn, S.B., Schulz-Knappe, P., Nice, E., Baker, M.S.

    Published in Journal of proteomics (08-09-2015)
    “…The low molecular weight (LMW; <10kDa)* plasma peptidome has been considered a source of useful diagnostic biomarkers and potentially therapeutic molecules, as…”
    Get full text
    Journal Article
  4. 4

    High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS) by Mohamedali, A M, Gäken, J, Ahmed, M, Malik, F, Smith, A E, Best, S, Mian, S, Gaymes, T, Ireland, R, Kulasekararaj, A G, Mufti, G J

    Published in Leukemia (01-09-2015)
    “…Bone marrow (BM) genetic abnormalities in myelodysplastic syndrome (MDS) have provided important biological and prognostic information; however, frequent BM…”
    Get full text
    Journal Article
  5. 5

    Preclinical modeling of myelodysplastic syndromes by Rouault-Pierre, K, Mian, S A, Goulard, M, Abarrategi, A, Di Tulio, A, Smith, A E, Mohamedali, A, Best, S, Nloga, A-M, Kulasekararaj, A G, Ades, L, Chomienne, C, Fenaux, P, Dosquet, C, Mufti, G J, Bonnet, D

    Published in Leukemia (01-12-2017)
    “…Myelodysplastic syndromes (MDS) represent a heterogeneous group of hematological clonal disorders. Here, we have tested the bone marrow (BM) cells from 38 MDS…”
    Get full text
    Journal Article
  6. 6

    Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B by Cheung, Lawrence H, Zhao, Yunli, Alvarez-Cienfuegos, Ana, Mohamedali, Khalid A, Cao, Yu J, Hittelman, Walter N, Rosenblum, Michael G

    “…Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B by Alvarez de Cienfuegos, Ana, Cheung, Lawrence H, Mohamedali, Khalid A, Whitsett, Timothy G, Winkles, Jeffrey A, Hittelman, Walter N, Rosenblum, Michael G

    Published in Journal for immunotherapy of cancer (01-09-2020)
    “…Antibody-drug conjugates are an exceptional and useful therapeutic tool for multiple diseases, particularly for cancer treatment. We previously showed that the…”
    Get full text
    Journal Article
  9. 9

    Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET by Rodriguez-Porcel, Martin, Cai, Weibo, Gheysens, Olivier, Willmann, Jurgen K, Chen, Kai, Wang, Hui, Chen, Ian Y, He, Lina, Wu, Joseph C, Li, Zi-bo, Mohamedali, Khalid A, Kim, Sehoon, Rosenblum, Michael G, Chen, Xiaoyuan, Gambhir, Sanjiv Sam

    Published in Journal of Nuclear Medicine (01-04-2008)
    “…Myocardial infarction (MI) leads to left ventricular (LV) remodeling, which leads to the activation of growth factors such as vascular endothelial growth…”
    Get full text
    Journal Article
  10. 10

    Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein by Mohamedali, Khalid A., Rosenblum, Michael G.

    Published in Biomedicines (17-07-2017)
    “…Angiogenesis is a critical process in numerous diseases, and intervention in neovascularization has therapeutic value in several disease settings, including…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF121/rGel fusion toxin by Weyergang, Anette, Cheung, Lawrence H., Rosenblum, Michael G., Mohamedali, Khalid A., Peng, Qian, Waltenberger, Johannes, Berg, Kristian

    Published in Journal of controlled release (28-04-2014)
    “…Vascular targeting for cancer is increasingly recognized as a therapeutic strategy although the lack of objective responses and the development of resistance…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel by MOHAMEDALI, Khalid A, POBLENZ, Ann T, SIKES, Charles R, NAVONE, Nora M, THORPE, Philip E, DARNAY, Bryant G, ROSENBLUM, Michael G

    Published in Cancer research (Chicago, Ill.) (15-11-2006)
    “…The pathophysiology of tumor growth following skeletal metastases and the poor response of this type of lesion to therapeutic intervention remains incompletely…”
    Get full text
    Journal Article
  16. 16

    Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2 by Mohamedali, Khalid A, Ran, Sophia, Gomez-Manzano, Candelaria, Ramdas, Latha, Xu, Jing, Kim, Sehoon, Cheung, Lawrence H, Hittelman, Walter N, Zhang, Wei, Waltenberger, Johannes, Thorpe, Philip E, Rosenblum, Michael G

    Published in BMC cancer (17-08-2011)
    “…Abstract Background: The fusion protein VEGF121 /rGel composed of the growth factor VEGF121 and the plant toxin gelonin targets the tumor neovasculature and…”
    Get full text
    Journal Article
  17. 17

    PET of Vascular Endothelial Growth Factor Receptor Expression by Cai, Weibo, Chen, Kai, Mohamedali, Khalid A, Cao, Qizhen, Gambhir, Sanjiv S, Rosenblum, Michael G, Chen, Xiaoyuan

    Published in The Journal of nuclear medicine (1978) (01-12-2006)
    “…For solid tumors and metastatic lesions, tumor vascularity is a critical factor in assessing response to therapy. Here we report the first example, to our…”
    Get full text
    Journal Article
  18. 18

    Sensitive Angiogenesis Imaging of Orthotopic Bladder Tumors in Mice Using a Selective Magnetic Resonance Imaging Contrast Agent Containing VEGF121/rGel by Cho, Eun-Jin, Yang, Jaemoon, Mohamedali, Khalid A, Lim, Eun-Kyung, Kim, Eun-Jung, Farhangfar, Carol J, Suh, Jin-Suck, Haam, Seungjoo, Rosenblum, Michael G, Huh, Yong-Min

    Published in Investigative radiology (01-07-2011)
    “…OBJECTIVES:To investigate the efficiency of magnetic resonance imaging (MRI) contrast agents employing vascular endothelial growth factor (VEGF121)/rGel…”
    Get full text
    Journal Article
  19. 19

    Characterization and Mechanistic Studies of a Novel Melanoma-Targeting Construct Containing IκBa for Specific Inhibition of Nuclear Factor-κB Activity by Zhou, Hong, Liu, Yuying, Cheung, Lawrence H., Kim, Sehoon, Zhang, Weihe, Mohamedali, Khalid A., Anand, Preetha, Hittelman, Walter N., Aggarwal, Bharat B., Rosenblum, Michael G.

    Published in Neoplasia (New York, N.Y.) (01-10-2010)
    “…The transcription factor nuclear factor-κB (NF-κB) is a central mediator of growth and homeostasis for both normal and neoplastic cells. IκBα is the natural…”
    Get full text
    Journal Article
  20. 20

    Multiplexed PET Probes for Imaging Breast Cancer Early Response to VEGF121/rGel Treatment by Yang, Min, Gao, Haokao, Sun, Xilin, Yan, Yongjun, Quan, Qimeng, Zhang, Wendy, A. Mohamedali, Khalid, Rosenblum, Michael G, Niu, Gang, Chen, Xiaoyuan

    Published in Molecular pharmaceutics (04-04-2011)
    “…In this study, we applied multiplexed positron emission tomography (PET) probes to monitor glucose metabolism, cellular proliferation, tumor hypoxia and…”
    Get full text
    Journal Article